GlassScriptPhysician profile
Tammy A Fluker
NPI 1417514571
$272.94
in general payments reported to CMS, 2019-2025
9 companies · $56.57 in 2025
The $56.57 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $202 · 2024: $14.78 · 2025: $56.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $132.44 | 2023-2025 | Gattex, Trintellix |
| Axsome Therapeutics, INC. | $23.01 | 2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $20.29 | 2023 | Quviviq |
| Acadia Pharmaceuticals INC | $19.43 | 2023 | Daybue |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.59 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.24 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $14.78 | 2024 | Rexulti |
| Novo Nordisk INC | $14.24 | 2023 | Rybelsus |
| Lundbeck LLC | $13.92 | 2023 | Brintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Fluker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.